跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOTHYROXINE SODIUM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEVOTHYROXINE SODIUM FOR INJECTION
Authorized
STANDARD
LEVOTHYROXINE SODIUM FOR INJECTION
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
da45eaf6096e9d22
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
da45eaf6096e9d22
Drug Approval Canada Name
LEVOTHYROXINE SODIUM FOR INJECTION
Product Name
LEVOTHYROXINE SODIUM FOR INJECTION
Status
Marketed
Status Date
2019-11-15
Original Market Date
2019-11-15
Din
02461714
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription
Ahfs
68:36.04
Atc Original
H03AA01 LEVOTHYROXINE SODIUM
Atc Name
h 03 aa 01
Aig Number
0107794003
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
LEVOTHYROXINE SODIUM
200 MCG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
da45eaf6096e9d22
Type
Standard
Back to Health Canada Approvals